[ad_1]
“The price has not yet been finalized, we estimate production costs, but it will be less than 10 euros,” Bogillot told France Inter radio.
Pharmaceutical companies around the world are rushing to develop a vaccine against COVID-19, a respiratory disease that has already killed more than 887,000 people. people around the world, Reuters reports.
When asked about the vaccine being developed by competitors AstraZeneca, which is expected to cost around € 2.5 per dose, Bogillot said: “The price difference may be because we use our own internal resources, our researchers, our research centers. AstraZeneca outsources part of its production. “
Sanofi spokesmen, for their part, say the price of the vaccine dose will be determined during the third phase of clinical trials.
“We hope to establish the final price during the third phase of testing, when we know more about the dosage. At this time, any number is not exact. The price of less than 10 euros is only an option,” said the representatives.
Sanofi and GSK expect the third phase of clinical trials of the vaccine to begin in December and approval of the vaccine is expected in the first half of next year.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
